NASDAQ:XFOR

X4 Pharmaceuticals Stock Forecast

etoro logo Buy XFOR
*Your capital is at risk
$3.96
+0.0200 (+0.508%)
At Close: Jul 08, 2026
AI Analysis AI Analysis of XFOR AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add XFOR to Watchlist?
Some Reasons Why To Add XFOR:
  • +138.6% price growth over the last year
  • High gross margin of 79.4%
  • Lower volatility than the market (beta 0.35)
PDF

X4 Pharmaceuticals Inc. stock price up 0.508% on Wednesday
(Updated on Jul 08, 2026)

Sell candidate since Jul 07, 2026 Gain 0.51%

The X4 Pharmaceuticals Inc. stock price gained 0.508% on the last trading day (Wednesday, 8th Jul 2026), rising from $3.94 to $3.96. During the last trading day the stock fluctuated 3.91% from a day low at $3.84 to a day high of $3.99. The price has risen in 6 of the last 10 days but is still down by -1% for this period. Volume fell on the last day by -65 thousand shares and in total, 464 thousand shares were bought and sold for approximately $1.84 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the lower of a wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $3.94 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -4.04% during the next 3 months and, with a 90% probability hold a price between $3.78 and $4.47 at the end of this 3-month period.

XFOR Signals & Forecast

A buy signal was issued from a pivot bottom point on Tuesday, July 07, 2026, and so far it has risen 0.508%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The X4 Pharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $4.15 and $4.01. A break-up above any of these levels will issue buy signals.

Support, Risk & Stop-loss for X4 Pharmaceuticals Inc. stock

X4 Pharmaceuticals Inc. finds support from accumulated volume at $3.94 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.150 between high and low, or 3.91%. For the last week, the stock has had daily average volatility of 6.85%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (XFOR) For The Upcoming Trading Day Of Thursday 9th

For the upcoming trading day on Thursday, 9th we expect X4 Pharmaceuticals Inc. to open at $3.93, and during the day (based on 14 day Average True Range), to move between $3.84 and $4.08, which gives a possible trading interval of +/-$0.249 (+/-6.51%) up or down from last closing price. If X4 Pharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 6.51% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $3.94 (0.51%) than the resistance at $4.00 (1.01%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is X4 Pharmaceuticals Inc. stock A Buy?

X4 Pharmaceuticals Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -1.617 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 9, 2026 - $3.93 ( 0.758%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

XFOR Performance

Trading levels for XFOR

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 4.08 3.03%
R2 4.02 1.58%
R1 3.99 0.689%
Price 3.96
S1 3.87 -2.20%
S2 3.84 -3.10%
S3 3.78 -4.55%

Accumulated Volume Support & Resistance Levels

Level Price
R3 4.04 2.02%
R2 4.02 1.52%
R1 4.00 1.01%
Price 3.96
S1 3.94 -0.505%
S2 3.88 -2.02%
S3 3.68 -7.07%

FAQ

What is the symbol for X4 Pharmaceuticals Inc. Stock and on which exchange is it traded?
The symbol for X4 Pharmaceuticals Inc. is XFOR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell X4 Pharmaceuticals Inc. Stock?
X4 Pharmaceuticals Inc. holds several negative signals and is within a wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy X4 Pharmaceuticals Inc. Stock?
X4 Pharmaceuticals Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy X4 Pharmaceuticals Inc. Stock.

What's the current price of X4 Pharmaceuticals Inc. Stock?
As of the end of day on the Jul 08, 2026, the price of an X4 Pharmaceuticals Inc. (XFOR) share was $3.96.

What is the 52-week high and low for X4 Pharmaceuticals Inc. Stock?
The 52-week high for X4 Pharmaceuticals Inc. Stock is $4.83 and the 52-week low is $1.35.

What is the market capitalization of X4 Pharmaceuticals Inc. Stock?
As of the Jul 08, 2026, the market capitalization of X4 Pharmaceuticals Inc. is 373.506M.

When is the next earnings date for X4 Pharmaceuticals Inc.?
The upcoming earnings date for X4 Pharmaceuticals Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT X4 PHARMACEUTICALS INC.
X4 Pharmaceuticals
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase III clinical trial for the treatment of patients with warts, hypogammaglobulinemia, infections, and my...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
18.74% Jun 29
NMRK
$15.02
2.53% Jun 24
X
XMAX
$8.34
3.48% Jun 24
JLL
$299.78
8.09% Jun 24
TTEK
$28.04
9.81% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE